Michael R. Bristow

Insider Reports History

Entity
Individual
Signature
/s/ C. Jeffrey Dekker, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael R. Bristow:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ARCA biopharma, Inc. Pres. & Chief Executive Offic, Director Common Stock 2.29 K $5.71 K $2.50 Dec 14, 2021 Direct
ARCA biopharma, Inc. Pres. & Chief Executive Offic, Director Common Stock 1.41 K $3.54 K $2.50 Dec 14, 2021 By NFS Custodian for Michael Bristow's IRA
ARCA biopharma, Inc. Pres. & Chief Executive Offic, Director Common Stock 1.11 K $2.77 K $2.50 Dec 14, 2021 By InvestocorTrust as sole Trustee
ARCA biopharma, Inc. Pres. & Chief Executive Offic, Director Stock Option (right to buy) 95 K Dec 14, 2021 Direct

Insider Reports Filed by Michael R. Bristow

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ABIO ARCA biopharma, Inc. Dec 14, 2021 1 $0 4 Dec 16, 2021 Pres. & Chief Executive Offic, Director